Welcome to ZisNews!

Read your favorite news, except the excluded topics, by you. Register
No overlapping ads for registered users

Madhya Pradesh HC denies bail to doctor Praveen Soni in Coldrif death case

Posted on: Feb 17, 2026 18:51 IST | Posted by: Hindustantimes
Madhya Pradesh HC denies bail to doctor Praveen Soni in Coldrif death case
JAbalpur: The Madhya Pradesh heights margaret court’s jubbulpore bench on tues dismissed the bond plea of paediatrician Praveen Soni, who was arrested last October for allegedly continuing to prescribe Coldrif — the cough syrup linked to at least 17 deaths in Madhya Pradesh and four in Rajasthan.A single bench of Justice Pramod Agrawal said, “The trial court shall proceed with the matter uninfluenced by any observations made by this court and shall decide the case strictly in accordance with law.”The order said, “Despite the conversation between the child specialist Praveen Khapekar and Soni, in which Khapekar informed him that 33 children died in Delhi in 1998 due to DEG-contaminated cough syrup and that a similar reaction might occur this time, Soni continued to prescribe the cough syrup. This resulted in the deaths of over 26 innocent children under the age of four or five, causing widespread harm to public health. Furthermore, Soni allegedly received a commission for prescribing the cough syrup and co-accused individuals destroyed evidence related to the syrup to protect the applicant (doctor).”The order concluded that this was not a suitable case to grant bail to the applicant.Soni, who was posted at the Civil Hospital in Parasia in Chhindwara district, was arrested on October 5 under Bharatiya Nyaya Sanhita (BNS) Sections 276 (adulteration of drugs) and 105 (culpable homicide not amounting to murder), and relevant sections of the Drugs and Cosmetics Act, 1940 (for brevity, “Act of 1940”), based on a complaint lodged by Ankit Sehlam, block medical officer of Parasiya.“Despite the death of a child on September 4, he continued prescribing the dangerous cough syrup to children, including those under four years of age, for whom the syrup was prohibited,” Sehlam alleged.The first child death linked to Coldrif was reported in Chhindwara on September 4, but the syrup continued to be prescribed. As more cases emerged across multiple states, health authorities launched a broader investigation. Laboratory tests revealed that the syrup contained diethylene glycol (DEG) — a toxic industrial solvent — in alarmingly high concentrations. DEG is commonly used in products like brake fluid and antifreeze and, when consumed, can cause acute kidney failure/Acute Tubular Necrosis (ATN) and death within 24 hours. Madhya Pradesh, Kerala, Tamil Nadu, Karnataka, Rajasthan and Telangana have now banned the sale of Coldrif.While the permissible limit for DEG in medicines is just 0.1%, government laboratory and drug department reports of Coldrif samples collected from shops in Chhindwara, where the deaths took place, showed up to 46.2% of the chemical.Some of the children allegedly died after being referred to a medical college hospital in Nagpur, Maharashtra. The medicine was allegedly sold by co-accused Jyoti Soni, who was working at Apna Medical Store, owned by her husband, Praveen Soni.Jyoti Soni allegedly sold “Coldriff Syrup” without a prescription. It is further submitted that when Soni prescribed the alleged cough syrup, he received a 10% commission on each bottle and the co-accused gained a profit of ₹23 per bottle. Hence, the couple allegedly received commission and profit from prescribing and selling the cough syrup. They were allegedly in collusion and each received commission/profit as per his or her respective role.

Global News Perspectives

In today's interconnected world, staying informed about global events is more important than ever. ZisNews provides news coverage from multiple countries, allowing you to compare how different regions report on the same stories. This unique approach helps you gain a broader and more balanced understanding of international affairs. Whether it's politics, business, technology, or cultural trends, ZisNews ensures that you get a well-rounded perspective rather than a one-sided view. Expand your knowledge and see how global narratives unfold from different angles.

Customizable News Feed

At ZisNews, we understand that not every news story interests everyone. That's why we offer a customizable news feed, allowing you to control what you see. By adding keywords, you can filter out unwanted news, blocking articles that contain specific words in their titles or descriptions. This feature enables you to create a personalized experience where you only receive content that aligns with your interests. Register today to take full advantage of this functionality and enjoy a distraction-free news feed.

Like or Comment on News

Stay engaged with the news by interacting with stories that matter to you. Like or dislike articles based on your opinion, and share your thoughts in the comments section. Join discussions, see what others are saying, and be a part of an informed community that values meaningful conversations.

Download the Android App

For a seamless news experience, download the ZisNews Android app. Get instant notifications based on your selected categories and stay updated on breaking news. The app also allows you to block unwanted news, ensuring that you only receive content that aligns with your preferences. Stay connected anytime, anywhere.

Diverse News Categories

With ZisNews, you can explore a wide range of topics, ensuring that you never miss important developments. From Technology and Science to Sports, Politics, and Entertainment, we bring you the latest updates from the world's most trusted sources. Whether you are interested in groundbreaking scientific discoveries, tech innovations, or major sports events, our platform keeps you updated in real-time. Our carefully curated news selection helps you stay ahead, providing accurate and relevant stories tailored to diverse interests.

Login to Like (0) Login to Dislike (0)

Login to comment.

No comments yet.